2. Search Result
Search Result
Results for "

C2 L-Erythro ceramide (d18:1/2:0)

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

1

Biochemical Assay Reagents

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-154831
    C22-Ceramide

    N-Behenoyl-D-Erythro-sphingosine; Cer d18:1/22:0

    		 Liposome Metabolic Disease
    C22-Ceramide (Cer d18:1/22:0) is an endogenous bioactive sphingolipid. C22-Ceramide reduces the propensity of C16-ceramide channel formation in isolated rat liver mitochondria and in liposomes .
    C22-Ceramide
  • HY-165064
    C2 L-Erythro ceramide (d18:1/2:0)

    L-Erythro cer(d18:1/2:0); N-Acetyl-L-Erythro-sphingosine; Acetyl-L-Erythro-sphingosine

    		 Others Cancer
    C2 L-Erythro ceramide (d18:1/2:0) is a cell-permeable sphingolipid. C2 L-Erythro ceramide (d18:1/2:0) induces cell cycle arrest in the G0/G1 phase and inhibits cell growth .
    C2 L-Erythro ceramide (d18:1/2:0)
  • HY-115703
    C17 Ceramide (d18:1/17:0)

    N-Heptadecanoyl-D-Erythro-sphingosine

    		 Biochemical Assay Reagents Metabolic Disease
    C17 Ceramide (d18:1/17:0) (N-Heptadecanoyl-D-erythro-sphingosine) is an ester product.
    C17 Ceramide (d18:1/17:0)
  • HY-158873
    N,N-Dihexyl sphingosine (d18:1/6:0/6:0)

    N,N-Dihexyl-D-Erythro-sphingosine

    		 Endogenous Metabolite Neurological Disease
    N,N-Dihexyl sphingosine (d18:1/6:0/6:0) (N,N-Dihexyl-D-erythro-sphingosine) is a synthetic analog of C18-Ceramide (HY-100355).
    N,N-Dihexyl sphingosine (d18:1/6:0/6:0)
  • HY-139062
    C6 Urea Ceramide

    C6 ceramide (d18:1/6:0) Urea; Cer(d18:1/6:0) Urea; D-Erythro-Urea-C6-ceramide

    		 Apoptosis Ceramidase Autophagy β-catenin Cancer
    C6 Urea Ceramide (Cer(d18:1/6:0) Urea) is an inhibitor of neutral ceramidase. C6 Urea Ceramide increases total ceramide levels in wild-type mouse embryonic fibroblasts (MEFs) and HT-29 colon cancer cells. C6 Urea Ceramide (5-10 μM) inhibits proliferation of HT-29 cells and induces apoptosis and autophagy, but is not toxic to non-cancerous cells. C6 Urea Ceramide decreases total and phosphorylated β-catenin levels in HT-29 and HCT116 cells, and induces colocalization of β-catenin with the 20S proteasome. C6 Urea Ceramide (1.25, 2.5, and 5 mg/kg) reduced tumor growth and increased C16, C18, C20, and C24 ceramide levels in tumor tissues in the HT-29 mouse xenograft model.
    C6 Urea Ceramide
  • HY-165087
    C6 Biotin ceramide (d18:1/6:0)

    N-Hexanoyl-biotin-D-Erythro-sphingosine

    		 Biochemical Assay Reagents Others
    C6 Biotin ceramide (d18:1/6:0) is a biochemical reagent.
    C6 Biotin ceramide (d18:1/6:0)
  • HY-170035
    GlcCer (d18:1/18:0)

    C18 Glucosyl(β) ceramide (d18:1/18:0); D-glucosyl-β-1,1' N-stearoyl-D-Erythro-sphingosine

    		 Liposome Neurological Disease
    GlcCer (d18:1/18:0) (C18 Glucosyl(β) ceramide (d18:1/18:0)) is a glycosphingolipid. GlcCer (d18:1/18:0) is promising for research of Parkinson disease and dementia with Lewy bodies .
    GlcCer (d18:1/18:0)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: